Pharmacovigilance Analysis of Azelastine-Related Adverse Events: Insights from the FDA FAERS Database (2006-2024) [0.03%]
阿扎他莫相关不良事件的药物流行病学分析：来自美国食品药品监督管理局FAERS数据库（2006-2024）的见解
Feihong Liang,Lulu Chen,Caixi Hu et al.
Feihong Liang et al.
Background: Azelastine is widely used in the treatment of allergic rhinitis, and it is necessary to gain insight into the true extent of adverse events (AEs) associated with it. ...
Assessing the Risk of Drug-Induced Influenza-Like Illness: A Disproportionality Analysis of Two Decades of FAERS Data (2004-2025) [0.03%]
基于2004-2025年FAERS数据库的信号分析，评估药物性流感样疾病的风险
Xing Gao,Xhuang Chen,Jie Zu et al.
Xing Gao et al.
Introduction: With the rising incidence of Influenza-like Illness (ILI), comprehensive studies on causative drugs remain lacking. This study aimed to detect drugs associated with ILI through disproportionality analysis of...
Pharmacovigilance Assessment of Thrombotic Adverse Events Linked to GLP-1 Receptor Agonists: Analysis of FAERS Reports from 2020-2025 [0.03%]
2020年至2025年FAERS报告中与GLP-1受体激动剂相关的血栓不良事件的药物流行病学评估
Eman M Mansory,Osman O Radhwi
Eman M Mansory
Introduction: Glucagon-like peptide-1 receptor agonists are widely prescribed for diabetes and obesity. The association between GLP-1 RAs and thrombotic events remains unclear, with conflicting evidence from clinical and ...
The Possible Protective Effect of Cerium Oxide Nanoparticles on Colistin-Induced Injury in Renal Cortex of Adult Male Albino Rats: Light and Electron Microscopic Study [0.03%]
纳米氧化铈对卡比莫司所致雄性成年Sprague-Dawley大鼠肾脏损伤的可能保护作用：光镜和电镜研究
Azza I Helal,Aml Younis Marei,Maha Mohamed Abo Gazia et al.
Azza I Helal et al.
Introduction: Acute Kidney Injury (AKI) is a rapid decline in renal function. Colistin, a last resort antibiotic for multidrug-resistant infections, is associated with significant nephrotoxicity. Cerium oxide nanoparticle...
Tenecteplase for Acute Ischemic Stroke: Improved Handling in Emergency Conditions [0.03%]
替奈普酶治疗急性缺血性卒中的研究进展——急诊条件下的使用优势
Antonio Siniscalchi,Luca Gallelli,Sabrina Anticoli et al.
Antonio Siniscalchi et al.
Tenecteplase, a genetically modified recombinant tissue plasminogen activator with a long half-life, has recently been proposed as a valid alternative to alteplase for thrombolysis in patients with acute ischemic stroke. According to clinic...
Descriptive Analysis of Adverse Drug Events of Three mTOR Inhibitors Using WHO-VigiAccess [0.03%]
利用WHO-VigiAccess分析三种mTOR抑制剂的不良事件描述
Prerna Bhati,Prakash Haloi,Havagiray R Chitme
Prerna Bhati
Introduction: The mechanistic target of rapamycin (mTOR) pathway regulates cell growth, metabolism, and survival. Its dysregulation contributes to cancer, autoimmune disorders, neurodegeneration, and aging. While mTOR inh...
Liraglutide Causing Pancreatitis in an Indian Obese Female: A Case Report and Review of the Literature [0.03%]
利拉鲁肽致印度肥胖女性胰腺炎一例及相关文献回顾
Jitendra Singh,Anju Dinkar,Rajeev Verma et al.
Jitendra Singh et al.
Introduction: Liraglutide, a glucagon-like peptide-1 receptor agonist (GLP-1 RA), is commonly prescribed for obesity and type 2 diabetes mellitus (T2DM). While its metabolic benefits are well-established, rare cases of ac...
Comparison of the Effects of Low-Dose Versus Standard-Dose Cyproheptadine on BMI Increase in Children and Assessment of its Adverse Drug Reactions: A Randomized Clinical Trial [0.03%]
低剂量与标准剂量盐酸赛庚啶对儿童增重影响的比较及不良反应评估的随机对照试验
Negar Javidmehr,Tina Talakesh,Hadi Raeisi et al.
Negar Javidmehr et al.
Introduction/objective: Childhood underweight and low body mass index are major public health concerns. There is no definitive evidence on the dosage adjustment of Cyproheptadine as an appetite stimulant. This study aimed...
Clinical Trial
Current drug safety. 2026 Apr 22. DOI:10.2174/0115748863470780260417103722 2026
The Treatment of Nociceptive Pain in DOAC-treated Patients: Could it be Safe? [0.03%]
DOAC治疗患者的 nociceptive 疼痛的处理：可能是安全的吗？
Gianmarco Marcianò,Vincenzo Rania,Cristina Vocca et al.
Gianmarco Marcianò et al.
Direct oral anticoagulants (DOACs) are widely prescribed in patients at risk of thromboembolism. Although they are generally safer than warfarin, DOACs still carry a risk of bleeding and drug-drug interactions (DDIs). Nociceptive pain is co...
Suspected Cutaneous Adverse Reaction Due to Oral Consumption of Siddha Polyherbo-Mineral Formulation, Gandhaga Rasayanam: A Case Report [0.03%]
疑似因服用锡达Ha药理-矿物制剂Gandhaga Rasayanam所致的皮肤不良反应：病例报告
T Subathra,N Chandan,Manish Barvaliya et al.
T Subathra et al.
Introduction: The Siddha formulation Gandhaga Rasayanam (GRM) is a classical polyherbo-mineral medicine containing purified sulphur and other herbal ingredients, including Schedule E(1) drugs. It is traditionally used to ...